Skip to main content

Roche Inks Reagents Distribution Deal with Sigma-Aldrich

NEW YORK (GenomeWeb) – Sigma-Aldrich today announced it has signed an agreement with Roche to become the exclusive global distributor of Roche's Biochemical Reagents products portfolio.

Under the terms of the agreement, Sigma-Aldrich will employ its sales, marketing, and e-commerce expertise, and relationships with the scientific community to present and distribute the Roche reagents. The Roche products include kits and enzymes for cellular analysis, proteomics, and conventional PCR applications.

Financial details of the agreement were not disclosed.

"The addition of these life science tools supports our strategy to augment our portfolio with products that accelerate customer scientific research programs," Eric Green, president of Sigma-Aldrich Research, said in a statement.

The agreement will allow Roche to devote more resources to its primary areas of focus, added Paul Brown, head of Roche Molecular Diagnostics.

Sigma-Aldrich will take over distribution of the Roche portfolio sometime this year, the firm said in a statement. Until then, the products will continue to be available through existing Roche channels.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.